Structure Search
AG01FO0L
23313-68-0 | Verapamil HCl
AG01FO0L
SDS
COATIP
This product is typically in stock.Please contact us for
quotation.
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
- mg
- g
- kg
- ml
- L
无数据
无数据
| CAS Number | 23313-68-0 |
| Catalog Number | AG01FO0L(AGN-PC-0QZO7P) |
| Chemical Name | Verapamil HCl |
| IUPAC Name | 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride |
| InChI | InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H |
| InChI Key | DOQPXTMNIUCOSY-UHFFFAOYSA-N |
| MDL Number | MFCD00055208 |
| Molecular Formula | C27H39ClN2O4 |
| Molecular Weight | 491.0626 |
| SMILES | |
| Synonyms | Calan,
Cordilox,
Dexverapamil,
Falicard,
Finoptin,
Hydrochloride, Verapamil,
Iproveratril,
Isoptin,
Isoptine,
Izoptin,
Lekoptin,
Verapamil,
Verapamil Hydrochloride,
Verapamil hydrochloride,
Verapamil HCl,
152-11-4,
Manidon,
Calcan hydrochloride,
Cordilox,
Cardibeltin,
Cardiabeltin,
Cardioprotect,
Veroptinstada,
Calaptin,
Caveril,
Civicor,
Coraver,
Corpamil,
Durasoptin,
Harteze,
Hexasoptin,
Hormitol,
Ikapress,
Inselon,
Isoptino,
Jenapamil,
Lodixal,
Magotiron,
Praecicor,
Robatelan,
Vasomil,
Vasopten,
Verabeta,
Veracor,
Verahexal,
Veraloc,
Veramil,
Verapin,
Verasal,
Verasifar,
Veratensin,
Verdilac,
Vetrimil,
Elthon,
Flamon,
Ikacor,
Univex,
Vortac,
(+/-)-VERAPAMIL HYDROCHLORIDE,
Anpec,
Ormil,
Rapam,
Verapamil Ebewe,
Verapamil Riker,
Verapamil Verla,
Civicor Retard,
Isoptin Retard,
Manidon Retard,
Vera-Sanorania,
Verapamil Acis,
Verapamil Atid,
Verapamil Basics,
Verapamil Nordic,
Verapamil-AbZ,
Novapamyl LP,
Verapamil NM,
Verapamil PB,
Verapamil SR,
Cordilox SR,
Dilacoran HTA,
Veracaps SR,
Verapamil MSD,
Hexasoptin Retard,
Verapamil Henning,
Arpamyl LP,
Verelan SR,
Verapamil Injection,
Berkatens,
Cardiagutt,
Dignover,
Geangin,
Izoptin,
Lekoptin,
Veramex,
Verpamil,
Akilen,
Quasar,
Univer,
Verapamil chloridrate,
Verapamil NM Pharma,
Calaptin 240 SR,
Novo-Veramil,
Verapress 240 SR,
D-365 hydrochloride,
Verapamil AL,
Verapamyl hydrochloride,
Apo-Verap,
Isoptin SR,
Nu-Verap,
Covera-HS,
Calan SR,
23313-68-0,
Iproveratril hydrochloride,
Verapamil (hydrochloride),
HSDB 3928,
EINECS 205-800-5,
NSC 272366,
LU 20175,
MLS000069485,
(+/-)-Verapamil, Hydrochloride,
NSC 135784,
MFCD00055208,
NSC657799,
Verapamil Hydrochloride (Isoptin, Iproveratril, Calan),
SMR000059109,
38176-10-2,
5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride,
5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride,
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride,
Q-201923,
(+/-)-Verapamil hydrochloride, 99+%,
(+-)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride,
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile hydrochloride,
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile, chloride,
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (+-)-,
Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-, monohydrochloride,
NSC272366,
SR-01000000050,
Covera,
verapami-hcl,
Verapamil, HCl,
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride,
Prestwick_440,
Vasolan (TN),
Verapamil hydrochloride [USAN:JAN],
Verelan (TN),
Covera-hs (TN),
Calan (TN),
Isotopin hydrochloride,
Verapamil hydrochloride [USAN:USP:JAN],
Opera_ID_1210,
()-Verapamil hydrochlorid,
CAS-152-11-4,
(y)-Verapamil hydrochloride,
AC1L1Y4V,
AC1Q3CE8,
(?)-Verapamil hydrochloride,
CHEMBL1280,
DSSTox_CID_14095,
DSSTox_RID_79114,
Verapamil Hydrochloride,(S),
DSSTox_GSID_34095,
SCHEMBL33296,
C27H39ClN2O4,
MLS001055442,
MLS002222213,
(+-)-Verapamil hydrochloride,
(??)-Verapamil hydrochloride,
ARONIS24174,
C27H38N2O4.HCl,
SPECTRUM2300307,
DTXSID2034095,
BBC/320,
BIV1326,
DOQPXTMNIUCOSY-UHFFFAOYSA-N,
ZX-AFC000544,
HMS1568M04,
HMS1922J16,
Pharmakon1600-02300307,
BCP06465,
HY-A0064,
ZX-AS004533,
Tox21_201180,
Tox21_501237,
BG0353,
CCG-39491,
IN1425,
NSC759589,
s4202,
Verapamil hydrochloride (JP17/USP),
AKOS005267117,
AC-8483,
AN-7969,
API0024301,
CS-1685,
LP01237,
NSC-272366,
NSC-657799,
NSC-759589,
NCGC00024710-03,
NCGC00094479-01,
NCGC00094479-02,
NCGC00094479-03,
NCGC00094479-04,
NCGC00094479-05,
NCGC00258732-01,
NCGC00261922-01,
AC-16228,
AK124375,
AS-16018,
BC210130,
CC-35585,
R853,
SC-18887,
ST066908,
AB0018370,
LS-161199,
EU-0101237,
FT-0603360,
FT-0655647,
ST24050346,
SW196662-4,
36622-29-4,
D00619,
EN300-124002,
K-4825,
V 4629,
( inverted question mark)-Verapamil hydrochloride,
54236-EP2305219A1,
54236-EP2308562A2,
152V114,
A816666,
I06-0615,
SR-01000000050-2,
SR-01000000050-4,
SR-01000000050-11,
Z2210978706,
(+/-)-Verapamil hydrochloride, >=99% (titration), powder,
Verapamil Hydrochloride 1.0 mg/ml in Methanol (as free base),
Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard,
(+/-)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material,
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile hydrochloride,
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-propan-2-yl-pentanenitrile hydrochloride,
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride,
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride,
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile hydrochloride,
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride,
Benzeneacetonitrile,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride,
Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-,monohydrochloride,
Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material,
Falicard,
Finoptin,
Isoptine,
Isoptin,
Securon,
Verelan,
Calan,
Tarka,
Verelan PM,
Vasolan,
(R)-Gallopamil,
(+)-Gallopamil,
VERAPAMIL,
Gallopamil, (+)-,
(+)-Methoxyverapamil,
UNII-V8KE5XTM0I,
UNII-V3888OEY5R,
R(+)-VERAPAMIL,
VERAPAMILHYDROCHLORIDE,
C27H38N2O4.ClH,
V3888OEY5R,
(S)-(-)-Verapamil Hydrochloride,
CID62969,
C27-H38-N2-O4.Cl-H,
EINECS 245-579-2,
CS-O-02558,
D-D-600,
V0118,
(+)-D 600,
Verapamil hydrochloride, 98%, a L-type Ca2 channel blocker - 1G 1g,
(+-)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride,
(1)-(3-Cyano-3-(3,4-dimethoxyphenyl)hex-6-yl)(5,6-dimethoxyphenethyl)methylammonium chloride,
?-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-?-(1-methylethyl)benzeneacetonitrile hydrochloride,
2-(3,4-dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile hydrochloride,
5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride,
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)benzeneacetonitrile, (R)-,
Bencenacrilonitrilo, alfa-[3-[[2-(3,4-dimetoxifenil) etil] metilamino] propil]-3,4-dimetoxi-alfa-(1-metiletil)-, clorhidrato (1:1),
Benzeneacetonitrile, .alpha.-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride,
Benzeneacetonitrile, ?-[3-[[2-(3,4-dimethoxyphenyl) ethyl]methylamino]propyl]-3,4-dimethoxy -?-(1-methylethyl)-, monohydrochloride,
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-, (alphaR)-,
|
| Complexity | 606 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 490.26g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 34 |
| Hydrogen Bond Acceptor Count | 6 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 491.069g/mol |
| Monoisotopic Mass | 490.26g/mol |
| Rotatable Bond Count | 13 |
| Topological Polar Surface Area | 64A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
GHS Hazard and Precautionary Statements
| Symbol: |
Certificate of Analysis
Lot Number
Product Recommendations
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited